Found: 9
Select item for more details and to access through your institution.
Cardiovascular Outcomes after Paclitaxel-Coated Balloon Angioplasty versus Drug-Eluting Stent Placement for Acute Coronary Syndrome: A Systematic Review and Meta-Analysis.
- Published in:
- Journal of Clinical Medicine, 2024, v. 13, n. 5, p. 1481, doi. 10.3390/jcm13051481
- By:
- Publication type:
- Article
Clinical effects of a selective urate reabsorption inhibitor dotinurad in patients with hyperuricemia and treated hypertension: a multicenter, prospective, exploratory study (DIANA).
- Published in:
- European Journal of Medical Research, 2023, v. 28, n. 1, p. 1, doi. 10.1186/s40001-023-01208-1
- By:
- Publication type:
- Article
Comparison of phrenic nerve injury and its effect on the extrapulmonary vein structures with cryoballoon and hot-balloon ablation systems: considering the lesion created on the superior vena cava as a surrogate marker.
- Published in:
- Heart & Vessels, 2023, v. 38, n. 5, p. 711, doi. 10.1007/s00380-022-02210-z
- By:
- Publication type:
- Article
Is creation of a fully circumferential lesion set necessary for laser balloon ablation-based pulmonary vein isolation?
- Published in:
- Journal of Interventional Cardiac Electrophysiology, 2023, v. 66, n. 3, p. 701, doi. 10.1007/s10840-022-01396-6
- By:
- Publication type:
- Article
Canagliflozin independently reduced plasma volume from conventional diuretics in patients with type 2 diabetes and chronic heart failure: a subanalysis of the CANDLE trial.
- Published in:
- Hypertension Research, 2023, v. 46, n. 2, p. 495, doi. 10.1038/s41440-022-01085-x
- By:
- Publication type:
- Article
Secondary analyses to assess the profound effects of empagliflozin on endothelial function in patients with type 2 diabetes and established cardiovascular diseases: The placebo‐controlled double‐blind randomized effect of empagliflozin on endothelial function in cardiovascular high risk diabetes mellitus: Multi‐center placebo‐controlled double‐blind randomized trial
- Published in:
- Journal of Diabetes Investigation, 2020, v. 11, n. 6, p. 1551, doi. 10.1111/jdi.13289
- By:
- Publication type:
- Article
Effects of canagliflozin in patients with type 2 diabetes and chronic heart failure: a randomized trial (CANDLE).
- Published in:
- ESC Heart Failure, 2020, v. 7, n. 4, p. 1585, doi. 10.1002/ehf2.12707
- By:
- Publication type:
- Article
Effect of Empagliflozin on Endothelial Function in Patients With Type 2 Diabetes and Cardiovascular Disease: Results from the Multicenter, Randomized, Placebo-Controlled, Double-Blind EMBLEM Trial.
- Published in:
- 2019
- By:
- Publication type:
- letter
Impact of irbesartan, an angiotensin receptor blocker, on uric acid level and oxidative stress in high-risk hypertension patients.
- Published in:
- Hypertension Research, 2015, v. 38, n. 11, p. 765, doi. 10.1038/hr.2015.82
- By:
- Publication type:
- Article